Clinical efficacy of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal patients with cholestasis

Jiang Lin, Qiuyu Jiang, Can YangArab 2025 · DOI

Abstract

Phenobarbital combined with ursodeoxycholic acid can improve the liver function of children to a greater extent in the treatment of neonatal cholestasis. It can also reduce serum bilirubin concentration, has good clinical efficacy, does not cause serious adverse reactions, and has good safety.
BibTeX
@inproceedings{lin2025clinical,
  author = {Jiang Lin and Qiuyu Jiang and Can Yang},
  title = {{Clinical efficacy of phenobarbital combined with ursodeoxycholic acid in the treatment of neonatal patients with cholestasis}},
  booktitle = {Arab},
  year = {2025},
  doi = {10.1016/j.ajg.2024.12.005},
}

Loading related content...

Figure